Identification and reduction of cryoinjury in endothelial cells: a first step toward establishing a cell bank for vascular tissue engineering.

We analyzed a cryopreservation protocol which improves long-term storage of endothelial cells (EC) for tissue engineering purposes. Human umbilical vein EC were frozen in a high-potassium solution containing 10% dimethyl sulfoxide using 3 different cooling rates. After a storage time in liquid nitrogen of 1, 4, or 12 months, samples were thawed and compared to fresh cells in terms of growth rates, anti-inflammatory, and anticoagulant functions. Independent of cooling rate and storage time, the retrieval after cryopreservation ranged between 60% and 80%. However, viability of the cells cryopreserved at 10 degrees C/min decreased significantly from 78 +/- 5% to 64 +/-3% with storage. Storage time of 4 months resulted in a decreased cell multiplication factor over 4 and 12 days in culture. The lag phases returned to normal in the next passage. Thawed cells showed increased metabolic activity, reduced expression of thrombomodulin, and unchanged basal expression of adhesion molecules. However, the tumor necrosis factor-induced expression of adhesion molecules was significantly increased after long-term storage. This effect was partially compensated after expansion of the cells, whereas the prostacyclin release increased. Expansion of cryopreserved/thawed EC resulted in highly proliferative cells with antithrombotic properties and a capacity for inflammatory reactions, which makes them suitable for vascular tissue engineering.

[1]  C. Hunt,et al.  Osmotic properties of the rabbit corneal endothelium and their relevance to cryopreservation , 1986, Cell Biophysics.

[2]  C. Peschel,et al.  [The STEMMAT-project as part of health initiative BayernAktiv: adult stem cells from umbilical cord and cord blood as alternative to embryonic stem cell research]. , 2006, Zentralblatt für Gynäkologie.

[3]  V. Jacobs,et al.  Cryopreservation of human endothelial cells for vascular tissue engineering. , 2005, Cryobiology.

[4]  J. Alder Körperbild und Sexualität nach Brustkrebs , 2005 .

[5]  Simon P Hoerstrup,et al.  Human umbilical cord cells for cardiovascular tissue engineering: a comparative study. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  K. Lehle,et al.  Expression of adhesion molecules and cytokines in vitro by endothelial cells seeded on various polymer surfaces coated with titaniumcarboxonitride. , 2003, Journal of biomedical materials research. Part A.

[7]  D. Pegg Cryopreservation of vascular endothelial cells as isolated cells and as monolayers. , 2002, Cryobiology.

[8]  D. Pegg,et al.  Differences in the requirements for cryopreservation of porcine aortic smooth muscle and endothelial cells. , 2001, Tissue engineering.

[9]  M. Guertin,et al.  Corneal Transplant Tolerance of Cryopreservation , 2001, Cornea.

[10]  T. Kitagawa,et al.  Viability of cryopreserved semilunar valves: an evaluation of cytosolic and mitochondrial activities. , 2000, The Annals of thoracic surgery.

[11]  W. Konertz,et al.  Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. , 2000, The Journal of thoracic and cardiovascular surgery.

[12]  G. Pascual,et al.  Rapid thawing increases the fragility of the cryopreserved arterial wall. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[13]  G. Sanz,et al.  Changes in the cooling rate and medium improve the vascular function in cryopreserved porcine femoral arteries. , 2000, Journal of vascular surgery.

[14]  Michael J. Taylor,et al.  Vitreous cryopreservation maintains the function of vascular grafts , 2000, Nature Biotechnology.

[15]  H. Dardik,et al.  Biological vascular grafts. , 1999, Seminars in Vascular Surgery.

[16]  R. Margreiter,et al.  Expression of stress proteins, adhesion molecules, and interleukin-8 in endothelial cells after preservation and reoxygenation. , 1999, Cryobiology.

[17]  J. Bellón,et al.  Coating PTFE vascular prostheses with a fibroblastic matrix improves cell retention when subjected to blood flow. , 1998, Journal of biomedical materials research.

[18]  U. V. von Oppell,et al.  In vitro endothelialization of expanded polytetrafluoroethylene grafts: a clinical case report after 41 months of implantation. , 1997, Journal of vascular surgery.

[19]  D. Pegg,et al.  Fractures in cryopreserved elastic arteries. , 1997, Cryobiology.

[20]  A. Pavie,et al.  Influence of arterial allograft preparation techniques on chronic vascular rejection: a histological study. , 1996, Transplantation Proceedings.

[21]  D. Loisance,et al.  Effects of cryopreservation on the proliferation and anticoagulant activity of human saphenous vein endothelial cells. , 1995, The Journal of thoracic and cardiovascular surgery.

[22]  J. Bellón,et al.  Behavior of cryopreserved endothelial cells in different phases: Their application in the seeding of vascular prostheses , 1995, Annals of vascular surgery.

[23]  C. Hunt,et al.  Fractures in cryopreserved arteries. , 1994, Cryobiology.

[24]  E. Minar,et al.  Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. , 1994, Journal of vascular surgery.

[25]  M. Adham,et al.  Cryopreserved arterial homografts: Preliminary study , 1993, Annals of vascular surgery.

[26]  P. Madden,et al.  The effect of polyvinylpyrrolidone and the cooling rate during corneal cryopreservation. , 1993, Cryobiology.

[27]  L. Bengtsson,et al.  Serial cultivation of adult human endothelium from the great saphenous vein. , 1992, Journal of vascular surgery.

[28]  V. Miller,et al.  Functional changes in canine saphenous veins after cryopreservation. , 1992, International Angiology.

[29]  M. Taylor,et al.  A new preservation solution for storage of corneas at low temperatures. , 1985, Current eye research.

[30]  J. Harlan,et al.  Role of hydrogen peroxide in the neutrophil-mediated release of prostacyclin from cultured endothelial cells. , 1984, The Journal of clinical investigation.